CN Stock MarketDetailed Quotes

600332 Guangzhou Baiyunshan Pharmaceutical Holdings

Watchlist
  • 29.06
  • +0.17+0.59%
Market Closed Dec 20 15:00 CST
47.25BMarket Cap13.80P/E (TTM)

Guangzhou Baiyunshan Pharmaceutical Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guangzhou Baiyunshan Pharmaceutical Holdings FY2024 9-Month Earnings Date

Currency：CNYOct 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
59.06B
--
+1.50%
EPS
--
1.94
--
-16.68%
Analyst Rating
Strong Buy

Dec 20, 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 24.762B--
--2024/Q4-- / 18.607B--
--2024/Q318.017B / 19.556B--
--2024/Q218.097B / 19.693B--
--2024/Q122.946B / 23.143B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 24.762B--
--2024/Q4-- / 18.607B--
--2024/Q318.017B / 19.556B--
--2024/Q218.097B / 19.693B--
--2024/Q122.946B / 23.143B--

Unlock Free Earnings Estimates

Guangzhou Baiyunshan Pharmaceutical Holdings Earnings Reports

  • Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Report for the third quarter of 2024

    Oct 25 12:00 ET

  • Full text of the 2024 semi-annual report of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

    Aug 30 12:00 ET

  • Summary of the 2024 semi-annual report of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

    Aug 30 12:00 ET

  • Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. 2024 First Quarter Report

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 20, 2024

    Strong Buy

    • Strong Buy

      60.00%

    • Buy

      40.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Superfungus
    Superfungus
    Intraday+1.17%
    Traditional Chinese Medicine Concept
    Traditional Chinese Medicine Concept
    Intraday+0.82%
    Bird Flu
    Bird Flu
    Intraday+0.81%